Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutamate receptor ionotropic, NMDA (Glycine Site) (NMDA receptor (glycine site))
- Target
- NMDA receptor (glycine site)
- Molecular classification
- Receptor, Ion channel, Ligand-gated ion channel, Glutamate receptor, Ionotropic glutamate receptor
01
Overview
The NMDA receptor’s glycine site is an obligatory coagonist recognition pocket located on its essential GluN1/NR1 subunits. Occupancy by either endogenous ligands like glycine or D-serine enables full activation only when coupled with concurrent glutamate binding at adjacent sites. This dual-ligand gating underpins many key processes in CNS physiology while also providing pharmacological opportunities for therapeutic intervention targeting cognitive function or neuroprotection through modulation at this unique allosteric regulatory node within excitatory synapses.
- Other names
- NMDA receptor glycine siteNMDAR glycine siteGlycine binding site of NMDA receptorGluN1 glycine binding site
02
Mechanism of action
Modulation of NMDA receptor activity via the glycine co-agonist binding site.
03
Biological functions
Synaptic plasticityMemory formationExcitatory neurotransmissionLong-term potentiation (LTP)Long-term depression (LTD)Neuronal developmentSynapse formation
04
Disease associations
Neurodegenerative diseasePsychiatric disordersEpilepsyStrokeSchizophreniaDepressionAlzheimer's diseaseParkinson's disease
05
Safety considerations
Excitotoxicity (overactivation of NMDARs)Psychomimetic effects (with some NMDAR antagonists)Cognitive impairment (potential side effect of NMDAR modulation)Neurodevelopmental effects (in pediatric populations)
06
Interacting drugs
Glycine
5 more in the full profile.
07
Biomarkers
Extracellular glycine concentrationNMDAR subunit expression levelsCSF glycine levelsPlasma D-serine levels
Beyond the preview
Go deeper on Glutamate receptor ionotropic, NMDA (Glycine Site) (NMDA receptor (glycine site)).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Glutamate receptor ionotropic, NMDA (Glycine Site) (NMDA receptor (glycine site)).